John Mauldin on the possibility of a coming biotech bubble and why he wants to be in early.
Biotech
Santa Claus Rally (reprise)
this post originally appeared on December 6th 2009 This post will be 99% anecdotal, 1% empirical, because I haven’t the time or energy to go dig up supporting data for what we all know: Most years, the market rips higher during the week between Christmas and New Year’s Eve and this one week run is…
Another Sell-Side Joke: Earnings Estimates for 2020
Here’s yet another exhibit for the jury to consider in the case of Sanity v. Sell-Side Research: Ladies and Gentlemen, I present Barclays Bank on Amylin Pharmaceuticals: Firm is introducing long term estimates for AMLN from 2011-2020 which assume exenatide LAR approval and launch in the US by 3Q10 and by 3Q11 in Europe. In…
